Menu Search
Equities

Medipal Holdings Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MEPDF:PKL

Medipal Holdings Corp

Actions
  • Price (USD)19.00
  • Today's Change0.00 / 0.00%
  • Shares traded200.00
  • 1 Year change+28.81%
  • Beta0.3334
Data delayed at least 15 minutes, as of Feb 04 2026 14:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Medipal Holdings Corp is a Japan-based company principally engaged in the wholesale of pharmaceuticals, cosmetics, daily necessities, and veterinary medicines. The Company operates in three segments. The Prescription Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as hospitals, clinics, and dispensing pharmacies. The Cosmetics, Daily Necessities, and General Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as drugstores, home improvement centers, convenience stores, and supermarkets. The Veterinary Medicines and Food Processing Raw Materials Wholesale Business segment engages in wholesale business targeting customers such as veterinary hospitals, livestock and fisheries producers, and processed food manufacturers. The Company also engages in preventive medicine, research and development of cutting-edge medical technology, non-life insurance agency services, and others.

  • Revenue in JPY (TTM)3.78tn
  • Net income in JPY41.46bn
  • Incorporated1923
  • Employees13.06k
  • Location
    Medipal Holdings Corp3-1-1, KyobashiCHUO-KU 104-8461JapanJPN
  • Phone+81 335175800
  • Fax+81 335175028
  • Websitehttps://www.medipal.co.jp
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.